Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

353 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
TP53 loss creates therapeutic vulnerability in colorectal cancer.
Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Rao PH, Maru DM, Pahl A, He X, Sood AK, Ellis LM, Anderl J, Lu X. Liu Y, et al. Among authors: ellis lm. Nature. 2015 Apr 30;520(7549):697-701. doi: 10.1038/nature14418. Epub 2015 Apr 22. Nature. 2015. PMID: 25901683 Free PMC article.
Cancer: The nuances of therapy.
Ellis LM, Reardon DA. Ellis LM, et al. Nature. 2009 Mar 19;458(7236):290-2. doi: 10.1038/458290a. Nature. 2009. PMID: 19295595 No abstract available.
Pragmatic issues in biomarker evaluation for targeted therapies in cancer.
de Gramont A, Watson S, Ellis LM, Rodón J, Tabernero J, de Gramont A, Hamilton SR. de Gramont A, et al. Among authors: ellis lm. Nat Rev Clin Oncol. 2015 Apr;12(4):197-212. doi: 10.1038/nrclinonc.2014.202. Epub 2014 Nov 25. Nat Rev Clin Oncol. 2015. PMID: 25421275 Review.
Chemotherapeutic drugs--more really is not better.
Fidler IJ, Ellis LM. Fidler IJ, et al. Among authors: ellis lm. Nat Med. 2000 May;6(5):500-2. doi: 10.1038/74969. Nat Med. 2000. PMID: 10802697 No abstract available.
353 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page